The Europe epirubicin market is expected to grow from US$ 51,079.61 thousand in 2022 to US$ 62,495.08 thousand by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028.
Increasing Awareness Regarding Cancer Drive Epirubicin Market
On March 8, 2021, the World Health Organization introduced the Global Breast Cancer Initiative to reduce breast cancer mortality by 2.5% annually until 2040, thereby preventing an estimated 2.5 thousand deaths. This initiative was presented on International Women's Day by the WHO in an advocacy event, "Hearing the call of women with breast cancer." Similarly, the WHO Global Initiative for Childhood Cancer was launched in September 2018 to increase the survival rate of children with cancer by ~60% by 2030 while reducing suffering and improving quality of life of these children. World Cancer Day held every February 4 since 2000, is the uniting initiative led by the Union for International Cancer Control (UICC). The UICC focuses on raising worldwide cancer awareness; improving education; catalyzing personal, collective, and government actions; and working together for the purpose of preventing cancer deaths. Therefore, increasing cancer awareness through various initiatives is driving the epirubicin market across Europe.
Market Overview
Europe held the second-largest share in the epirubicin market owing to factors such as the rising prevalence of cancer and the high demand for developing new chemotherapy drugs. The market growth is attributed to the increasing pharmaceutical production, growing product innovations by pharmaceutical companies, rising government support, and development of production facilities and infrastructures. In addition, growing funding for research & development activities in the pharmaceutical industry is likely to offer many opportunities in the coming years. The pharmaceutical industry is continuously expanding in the UK. According to Office National Statistics, 610 companies were operating in the UK in 2018, and has over 15 global companies headquartered in the UK. Also, approximately 41% of pharmaceutical production is exported to other European countries and regions. Companies such as Astra Zeneca, Eli Lilly, and GSK have contributed significantly to the growth of pharmaceuticals by leading research & development activities. The growth of these companies is expected to influence the market growth in the coming years. Moreover, the incidence rate of breast cancer in the UK is highest in people aged 90 or above. As per the Office for National Statistics national statistics (UK), in 2019, ~605,181 people were aged 90 years and over. Further, as per Cancer Research UK, every year, there are ~55,900 new breast cancer cases in the UK. As a result, the growing geriatric population is likely to increase the incidence rate of breast cancer. Thus, the factors mentioned above are driving the epirubicin market growth.
Europe Epirubicin Market Revenue and Forecast to 2028 (US$ Thousand)
Europe Epirubicin Market Segmentation
Europe epirubicin market is segmented based on dosage, application, distribution channel, and country
Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Mylan N.V., Pfizer Inc., Salius Pharma Pvt Ltd, and Teva Pharmaceutical Industries Ltd. are the leading companies operating in the Europe epirubicin market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 51,079.61 thousand |
| Market Size by 2028 | US$ 62,495.08 thousand |
| CAGR (2022 - 2028) | 3.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Dosage
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Epirubicin Market is valued at US$ 51,079.61 thousand in 2022, it is projected to reach US$ 62,495.08 thousand by 2028.
As per our report Europe Epirubicin Market, the market size is valued at US$ 51,079.61 thousand in 2022, projecting it to reach US$ 62,495.08 thousand by 2028. This translates to a CAGR of approximately 3.4% during the forecast period.
The Europe Epirubicin Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Epirubicin Market report:
The Europe Epirubicin Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Epirubicin Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Epirubicin Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Epirubicin Market
